WW International (WW) Q2 2024 earnings summary

Executive summary

• Q2 2024 revenue was $202.1 million with 3.8 million subscribers, a 6.1% year-over-year decline, but clinical subscribers grew 120%, reflecting strong adoption of new clinical offerings.

• Achieved record gross margin of 67.9% and implemented a one-membership strategy, allowing members to move between behavioral and clinical programs.

• Announced a $100 million annualized cost savings plan, with $20 million reflected in 2024 guidance, including a 40% reduction in VP and above roles.

• Strategic streamlining of operations and expansion across care, access, and payment options, including insurance-covered services and B2B partnerships.

• Shifted to a single reportable segment in 2024, reflecting centralized structure and planning.

Financial highlights

• Q2 2024 revenue was $202.1 million, down 10.9% year-over-year; subscription revenue declined 5.7%, but clinical subscription revenue grew 159.8% to $19.7 million.

• Adjusted gross margin reached a record 67.9%, up from 63.1% last year, driven by discontinuation of low-margin products.

• Adjusted operating income was $37.9 million (18.8% margin), up from $35.9 million, while GAAP EPS was $0.29, down from $0.65 year-over-year.

• Net income for Q2 2024 was $23.3 million, a 54.2% decrease year-over-year.

• Net debt to adjusted EBITDA/EBITDAS leverage ratio was 9.6x at quarter end.

Outlook and guidance

• Year-end 2024 subscriber guidance set at at least 3.1 million, with revenue of at least $770 million.

• Adjusted operating income expected to be at least $100 million and adjusted EBITDA at least $150 million.

• Cost reduction initiatives targeting $100 million in annualized savings, with $20 million reflected in 2024 guidance.

• 2024 restructuring charges estimated at $12–$15 million in the second half.

• Sufficient liquidity from $42.7 million cash and $173.8 million available under the Revolving Credit Facility.